Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.
about
Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease RiskHepcidin and Host Defense against Infectious Diseases.Chronic hepatitis C and liver fibrosis.Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.Processes to manage analyses and publications in a phase III multicenter randomized clinical trialHepatitis C, porphyria cutanea tarda and liver iron: an update.Quantification of liver iron with MRI: state of the art and remaining challenges.Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overloadThe impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening.Inhibition of hepcidin transcription by growth factors.Inverse Association of Plasma Level of Glutathione Peroxidase with Liver Fibrosis in Chronic Hepatitis B: Potential Role of Iron.Out of balance--systemic iron homeostasis in iron-related disordersPorphyrin and heme metabolism and the porphyrias.Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis.Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm.Natural history of HCV infection.A Single Center Study Comparing the Stainable Iron Depositions in 1000 Explanted Cirrhotic Livers of Different Causes.Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution.Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C.The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients.Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C.Serum ferritin and the risk of hepatocellular carcinoma in chronic liver disease of viral etiology: a case-control study.Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection.Impact of serum ferritin level on hepatocarcinogenesis in chronic hepatitis C patients.Ethnic and genetic factors of iron status in women of reproductive age.Hepatic iron overload in the portal tract predicts poor survival in hepatocellular carcinoma after curative resection.Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis.
P2860
Q26778935-C767C220-9451-487A-ABB5-E862C0F9AA32Q26796310-CCBD2ADC-969A-40F5-A513-E992E0DD07B5Q26825671-22BE493E-F15F-4B8F-B606-623EABE74DD9Q29417108-2BFD433E-08EC-4190-9E91-36F38D313282Q33694159-E90E1CE6-8A64-4B28-8A0F-FA9FC6971B98Q34268811-0711B61B-7FCD-495E-BFE3-03F954373D58Q35020698-4C60BB02-E4CF-43EA-82FB-3886AFD17395Q35185407-01B05C72-3AB1-4D43-BEB3-D5864C4337ABQ35590977-9882C665-419E-48C1-A68A-0C0085CF3D0FQ35665032-62876F8F-6FAE-4F61-BD41-5F69DAA9C5BAQ35996119-6B279811-B0E4-4B35-BBA5-D23CB5B736EEQ36948005-CEA96F2D-FB6C-4FBB-A705-4E7FBF6AF13BQ37177398-69412B75-41ED-4617-B1D4-BA4A58B6D6E8Q38110514-742220C6-5F36-414F-8B9A-45FEDD87F5B4Q38164077-C4FE2D28-9458-47E0-A98B-4DF343B22C53Q38446344-F1D995AC-17F9-43B9-B4FD-1994471901D1Q38552179-9CCE6726-5FAF-474F-A1AB-1533C38FA602Q38792716-90762698-CF38-4BA1-BD33-C325A0CD04E6Q38884441-575EC7F6-1BEA-4580-8CB1-B805D3DA0453Q39396566-9490C74A-3CAC-4FF1-8911-508E5D1EEB9FQ42184609-D8237FAF-346D-4C64-B3D2-D4968EB0B3F9Q42252393-A7B60C5D-FF91-41D8-91D0-BF0167FFE168Q42272134-F1AEEC03-EEA0-4FFE-AC8A-2FDDE88300E5Q42283903-665DAE5A-DE48-4B63-860E-B12087EF6D8CQ44104438-00D3D464-1DB8-408A-BD35-76EC149F8BD5Q47603638-63A894F5-406E-4F0A-B9CD-C204ECCB125EQ48361923-DFC80E16-3876-41E8-95D0-60C060B42DA7Q50142613-06F7FBCB-B8D4-4FC7-B8F8-022FCF84D309
P2860
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Iron levels in hepatocytes and ...... advanced chronic hepatitis C.
@ast
Iron levels in hepatocytes and ...... advanced chronic hepatitis C.
@en
Iron levels in hepatocytes and ...... advanced chronic hepatitis C.
@nl
type
label
Iron levels in hepatocytes and ...... advanced chronic hepatitis C.
@ast
Iron levels in hepatocytes and ...... advanced chronic hepatitis C.
@en
Iron levels in hepatocytes and ...... advanced chronic hepatitis C.
@nl
prefLabel
Iron levels in hepatocytes and ...... advanced chronic hepatitis C.
@ast
Iron levels in hepatocytes and ...... advanced chronic hepatitis C.
@en
Iron levels in hepatocytes and ...... advanced chronic hepatitis C.
@nl
P2093
P2860
P1433
P1476
Iron levels in hepatocytes and ...... advanced chronic hepatitis C.
@en
P2093
Anne M Stoddard
Chihiro Morishima
Deepa Naishadham
HALT-C Trial Group
Herbert L Bonkovsky
Richard K Sterling
Richard W Lambrecht
Thomas Rogers
Timothy R Morgan
P2860
P304
1490-500.e3
P356
10.1053/J.GASTRO.2011.01.053
P407
P577
2011-02-15T00:00:00Z